bioAffinity Technologies, Inc. (BIAF) vs Jaguar Health, Inc. (JAGX)
A side-by-side comparison of bioAffinity Technologies, Inc. and Jaguar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.00HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
JAGX
Jaguar Health, Inc.
$5.89HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — BIAF vs JAGX
growth of $100 · dividends reinvested · last 3yBIAF -95.9% (-65.6%/yr)JAGX -99.9% (-90.2%/yr)BIAF compounded faster over this window
Log scale — wide-divergence pair
BIAF JAGX
BIAF vs JAGX: by the numbers
- •JAGX is the larger company ($3M vs $3M market cap).
- •Both run net losses; JAGX's is the smaller (-131.76% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | BIAF | JAGX |
|---|---|---|
| P/S ratio | 0.43 | 0.09 |
| P/B ratio | 0.67 | 0.39 |
Profitability
| Metric | BIAF | JAGX |
|---|---|---|
| Gross margin | 23.21% | 67.21% |
| Operating margin | -171.58% | -391.87% |
| Net margin | -257.33% | -131.76% |
| ROE | -402.92% | -554.01% |
| ROIC | -237.93% | -110.81% |
Growth (annualized)
| Metric | BIAF | JAGX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 31.88% |
Go deeper
Dig into the metrics
bioAffinity Technologies ROEJaguar Health ROEbioAffinity Technologies operating marginJaguar Health operating marginbioAffinity Technologies revenue growthJaguar Health revenue growthbioAffinity Technologies free cash flowJaguar Health free cash flow
bioAffinity Technologies & Jaguar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.